Correction: Microbiome-innate immune crosstalk in acute exacerbation of idiopathic pulmonary fibrosis: an amplification framework - Scorecard - MDSpire

Correction: Microbiome-innate immune crosstalk in acute exacerbation of idiopathic pulmonary fibrosis: an amplification framework

  • By

  • Wanwan Zhang

  • Jiayang Yi

  • Zhi Li

  • May 12, 2026

  • 0 min

Share

Clinical Scorecard: Correction: Interactions Between the Microbiome and Innate Immunity During Acute Exacerbations of Idiopathic Pulmonary Fibrosis: A Framework for Amplification

At a Glance

CategoryDetail
ConditionIdiopathic Pulmonary Fibrosis (IPF)
Key MechanismsMicrobiome-innate immune crosstalk
Target PopulationPatients with Idiopathic Pulmonary Fibrosis
Care SettingClinical research and immunology

Key Highlights

  • Correction of funding statement in the original article
  • Financial support received from Anhui Province Graduate Education Quality Engineering Project
  • Grant No. 2023yjsxssfkc027 awarded to Zhi Li
  • Importance of microbiome interactions in IPF exacerbations
  • Framework for understanding immune responses in IPF

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients with acute exacerbations of IPF

          Focus on microbiome interactions and innate immunity

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Related Content